Skip to main content

Table 4 Demographic representativeness of respondents by survey mode, survey of Utah cancer survivors1

From: The feasibility of web surveys for obtaining patient-reported outcomes from cancer survivors: a randomized experiment comparing survey modes and brochure enclosures

 

Full sample

Paper

Web

  

Respondents

Adj. RR2

95% CI

P

Respondents

Adj. RR2

95% CI

P

n

Col.%

n

Col.%

n

Col.%

Time since diagnosis

 Long-term

192

43.0

43

37.7

1.00

Ref.

 

35

36.8

1.00

Ref.

 

 Short-term

254

57.0

71

62.3

1.36

1.01, 1.84

0.043

60

63.2

1.07

0.74, 1.54

0.719

Sex

 Female

252

56.5

74

64.9

1.39

0.91, 2.12

0.127

52

54.7

0.75

0.46, 1.22

0.249

 Male

194

43.5

40

35.1

1.00

Ref.

 

43

45.3

1.00

Ref.

 

Current age

  < 40

74

16.6

14

12.3

1.00

Ref.

 

13

13.7

1.00

Ref.

 

 40–49

126

28.3

34

29.8

1.34

0.83, 2.16

0.238

30

31.6

1.49

0.86, 2.59

0.157

 50–59

171

38.3

40

35.1

1.67

0.99, 2.80

0.053

34

35.8

1.06

0.59, 1.89

0.856

  > =60

75

16.8

26

22.8

1.78

1.02, 3.06

0.043

18

19.0

1.56

0.80, 3.06

0.196

Race

 White

416

93.3

108

94.7

1.00

Ref.

 

92

96.8

1.00

Ref.

 

 Nonwhite

30

6.7

6

5.3

0.76

0.41, 1.41

0.379

< 53

0.45

0.16, 1.29

0.138

Ethnicity

 Hispanic

68

15.5

15

13.4

0.90

0.60, 1.35

0.611

8

8.5

0.51

0.27, 0.96

0.036

 Non-Hispanic

372

84.6

97

86.6

1.00

Ref.

 

86

91.5

1.00

Ref.

 

Geography

 Rural

61

13.7

19

16.7

0.84

0.57, 1.21

0.347

10

10.5

0.91

0.55, 1.51

0.728

 Metropolitan

385

86.3

95

83.3

1.00

Ref.

 

85

89.5

1.00

Ref.

 

Cancer site

 Colorectal

128

28.7

26

22.8

1.00

Ref.

 

25

26.3

1.00

Ref.

 

 Myeloma

64

14.4

20

17.5

1.45

0.77, 2.73

0.256

13

13.7

0.78

0.40, 1.54

0.480

 Breast

97

21.8

27

23.7

0.92

0.57, 1.50

0.745

19

20.0

1.18

0.63, 2.21

0.597

 Ovarian

63

14.1

21

18.4

1.26

0.79, 2.03

0.334

16

16.8

1.51

0.85, 2.68

0.157

 Prostate

94

21.1

20

17.5

0.89

0.51, 1.56

0.687

22

23.2

1.22

0.72, 2.04

0.459

Stage

 In situ

24

5.4

7

6.1

1.00

Ref.

 

7

7.4

1.00

Ref.

 

 Localized

211

47.3

54

47.4

0.76

0.44, 1.30

0.313

39

41.1

0.74

0.37, 1.46

0.383

 Regional

114

25.6

23

20.2

0.60

0.34, 1.07

0.086

26

27.4

0.86

0.43, 1.71

0.667

 Distant

97

21.8

30

26.3

0.59

0.28, 1.21

0.149

23

24.2

1.11

0.52, 2.39

0.786

  1. 1. P-values for statistically significant comparisons are presented in boldface
  2. 2. Adjusted (Adj.) risk ratios from a multivariable model that adjusts for other variables in table
  3. 3. Cell counts less than five are masked for protection of confidentiality